The Canopy Growth (CGC) FQ2 quarter was so bad an investor will find the results very difficult to analyze in order to value the stock. As previously warned, the company had meager expectations for a supposed budding cannabis empire while any weak results were bound to crush the stock. In fact, investors should consider the closing price of just below $16 with a market cap of $5.3 billion as still highly stretched with the dramatically reduced exceptions in the Canadian market.
Image Source: Canopy Growth website
Hideous Numbers
For the quarter, Canopy